Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Update

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) saw a significant drop in short interest in the month of August. As of August 31st, there was short interest totalling 2,757,700 shares, a drop of 11.7% from the August 15th total of 3,121,400 shares. Based on an average daily trading volume, of 1,500 shares, the short-interest ratio is currently 1,838.5 days.

Genomma Lab Internacional Price Performance

Shares of GNMLF opened at $1.07 on Wednesday. Genomma Lab Internacional has a 1-year low of $0.79 and a 1-year high of $1.07. The firm’s 50 day simple moving average is $0.98 and its 200 day simple moving average is $0.94.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.